Provided by Tiger Fintech (Singapore) Pte. Ltd.

LUCID DIAGNOSTICS INC.

1.17
-0.0200-1.68%
Post-market: 1.13-0.0400-3.42%19:59 EDT
Volume:9.85M
Turnover:11.51M
Market Cap:126.59M
PE:-0.93
High:1.21
Open:1.20
Low:1.12
Close:1.19
Loading ...

Lucid Diagnostics Inc. Conducted Annual Stockholder Meeting

Reuters
·
19 Jun

Major California Health System Launches Comprehensive Esophageal Precancer Testing Program Using Lucid Diagnostics' Esoguard® Esophageal DNA Test

THOMSON REUTERS
·
19 Jun

Lucid Diagnostics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
06 Jun

Corrected-Lucid Diagnostics: Files for Offering of 37 Mln Shares of Common Stock by Selling Stockholders - SEC Filing (Corrects Figure, Adds Dropped Words)

THOMSON REUTERS
·
04 Jun

BRIEF-Lucid Diagnostics Files For Offering Of 36 Million Shares Of Common Stock

Reuters
·
04 Jun

Lucid Diagnostics Inc: Files for Offering of 36 Mln Shares of Common Stock - SEC Filing

THOMSON REUTERS
·
04 Jun

Lucid Diagnostics Inc - Enters Sales Agreement With Maxim Group - SEC Filing

THOMSON REUTERS
·
31 May

Lucid Diagnostics Inc. Announces $25 Million At-the-Market Share Offering Through Maxim Group LLC

Reuters
·
31 May

Lucid Diagnostics : May Offer, Sell Shares of Common Stock of up to $25 Mln

THOMSON REUTERS
·
31 May

Lucid Diagnostics to join Russell 2000, Russell 3000 indexes

TIPRANKS
·
27 May

Lucid Diagnostics director buys $457.6K in common stock

TIPRANKS
·
24 May

Director Dennis Matheis Acquires Common Shares of Lucid Diagnostics Inc

Reuters
·
23 May

Lucid Diagnostics Files Shelf Registration for Secondary Sale of 37 Million Shares by Convertible Note Holders

MT Newswires Live
·
22 May

BRIEF-Lucid Diagnostics Files Prospectus For Potential Offer, Sale From Time To Time Of Up To 37 Million Shares Of Common Stock By Selling Stockholders

Reuters
·
22 May

Lucid Diagnostics Files Prospectus for Potential Offer, Sale From Time to Time of up to 37 Mln Shares of Common Stock by Selling Stockholders

THOMSON REUTERS
·
22 May

Lucid Diagnostics Price Target Maintained With a $3.00/Share by Needham

Dow Jones
·
15 May

Lucid Diagnostics Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
14 May

Corrected-Lucid Diagnostics Inc: Qtrly Adj Loss per Share $0.16 (Not Gaap Loss)

THOMSON REUTERS
·
14 May

Lucid Diagnostics Q1 Adj. EPS $(0.16), Inline, Sales $800.00K Miss $1.28M Estimate

Benzinga
·
14 May

Lucid Diagnostics Inc: Qtrly Loss per Share $0.16

THOMSON REUTERS
·
14 May